Andrew Erickson

Andrew Erickson

University of Oxford

H-index: 13

Europe-United Kingdom

About Andrew Erickson

Andrew Erickson, With an exceptional h-index of 13 and a recent h-index of 12 (since 2020), a distinguished researcher at University of Oxford, specializes in the field of Prostate Cancer, Clinical Data Science, Tumor Microenvionment, Clonal Evolution, Intratumoral Heterogeneity.

His recent articles reflect a diverse array of research interests and contributions to the field:

MRI-Targeted Prostate Biopsy Introduces Grade Inflation and Overtreatment

Clonal phylogenies inferred from bulk, single cell, and spatial transcriptomic analysis of cancer

Spatial transcriptomic analysis of virtual prostate biopsy reveals confounding effect of tissue heterogeneity on genomic signatures

Abstract A051: The spatial landscape of clonal somatic copy number alterations in benign and malignant prostate epithelia

PP2A methylesterase PME‐1 suppresses anoikis and is associated with therapy relapse of PTEN‐deficient prostate cancers

Prognostic impact of kallikrein‐related peptidase transcript levels in prostate cancer

Open-source single-cell spatial image analysis pipeline for ten-plex immunofluorescence of histological prostate cancer tissue sections

IRF7 impacts on prostate cancer cell survival in response to radiation

Andrew Erickson Information

University

Position

___

Citations(all)

552

Citations(since 2020)

501

Cited By

180

hIndex(all)

13

hIndex(since 2020)

12

i10Index(all)

16

i10Index(since 2020)

15

Email

University Profile Page

Google Scholar

Andrew Erickson Skills & Research Interests

Prostate Cancer

Clinical Data Science

Tumor Microenvionment

Clonal Evolution

Intratumoral Heterogeneity

Top articles of Andrew Erickson

MRI-Targeted Prostate Biopsy Introduces Grade Inflation and Overtreatment

medRxiv

2024/1/10

Clonal phylogenies inferred from bulk, single cell, and spatial transcriptomic analysis of cancer

bioRxiv

2023/2/27

Spatial transcriptomic analysis of virtual prostate biopsy reveals confounding effect of tissue heterogeneity on genomic signatures

Molecular Cancer

2023/10/3

Abstract A051: The spatial landscape of clonal somatic copy number alterations in benign and malignant prostate epithelia

Cancer Research

2023/6/2

Prognostic impact of kallikrein‐related peptidase transcript levels in prostate cancer

International Journal of Cancer

2023/5/4

Open-source single-cell spatial image analysis pipeline for ten-plex immunofluorescence of histological prostate cancer tissue sections

Cancer Research

2023/4/4

Spatio-temporal analysis of prostate tumors in situ suggests pre-existence of treatment-resistant clones

Nature Communications

2022/9/17

Infectious complications after transrectal MRI-targeted and systematic prostate biopsy

World Journal of Urology

2022/9

Andrew Erickson
Andrew Erickson

H-Index: 8

Antti Rannikko
Antti Rannikko

H-Index: 28

Prospective longitudinal health-related quality of life analysis of the Finnish arm of the PRIAS active surveillance cohort: 11 years of follow-up

European Urology Focus

2022/9/1

Spatially resolved clonal copy number alterations in benign and malignant tissue

Nature

2022/8/11

Single-cell transcriptome and chromatin sequencing uncover gene expression and gene regulatory patterns associated with enzalutamide resistance

Cancer Research

2022/6/15

Multiplex immunohistochemical phenotyping of T cells in primary prostate cancer

The Prostate

2022/5

Andrew Erickson
Andrew Erickson

H-Index: 8

Gunes Guner
Gunes Guner

H-Index: 12

Cover Image: Volume 82 Issue 6

The Prostate

2022/5

Andrew Erickson
Andrew Erickson

H-Index: 8

Gunes Guner
Gunes Guner

H-Index: 12

MP45-14 THE SPATIAL LANDSCAPE OF CLONAL SOMATIC MUTATIONS IN BENIGN AND MALIGNANT PROSTATE EPITHELIA

The Journal of Urology

2022/5

The Movember Global Action Plan 1 (GAP1): Unique Prostate Cancer Tissue Microarray Resource

Cancer Epidemiology, Biomarkers & Prevention

2022/4/1

The spatial landscape of clonal somatic mutations in benign and malignant prostate epithelia

2021/7/30

Increased Expression and Altered Cellular Localization of Fibroblast Growth Factor Receptor-Like 1 (FGFRL1) Are Associated with Prostate Cancer Progression

Cancers

2022/1

See List of Professors in Andrew Erickson University(University of Oxford)